{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:29:59Z","timestamp":1768271399217,"version":"3.49.0"},"publisher-location":"Cham","reference-count":54,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030663056","type":"print"},{"value":"9783030663063","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/164_2019_348","type":"book-chapter","created":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T20:03:48Z","timestamp":1580760228000},"page":"251-264","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Botulinum Toxin and Pain"],"prefix":"10.1007","author":[{"given":"Zdravko","family":"Lackovi\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"issue":"14","key":"348_CR1","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","volume":"28","author":"F Antonucci","year":"2008","unstructured":"Antonucci F, Rossi C, Gianfranceschi L, Rossetto O, Caleo M (2008) Long-distance retrograde effects of botulinum neurotoxin A. J Neurosci 28(14):3689\u20133696. https:\/\/doi.org\/10.1523\/JNEUROSCI.0375-08.2008","journal-title":"J Neurosci"},{"issue":"Suppl 1","key":"348_CR2","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","volume":"43","author":"KR Aoki","year":"2003","unstructured":"Aoki KR (2003) Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache 43(Suppl 1):S9\u2013S15. https:\/\/doi.org\/10.1046\/j.1526-4610.43.7s.3.x","journal-title":"Headache"},{"issue":"5","key":"348_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2015","unstructured":"Aoki KR (2015) Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology 26(5):785\u2013793. https:\/\/doi.org\/10.1016\/j.neuro.2005.01.017","journal-title":"Neurotoxicology"},{"issue":"2","key":"348_CR4","first-page":"201","volume":"46","author":"L Bach-Rojecky","year":"2005","unstructured":"Bach-Rojecky L, Lackovi\u0107 Z (2005) Antinociceptive effect of botulinum toxin type a in rat model of carrageenan and capsaicin induced pain. Croat Med J 46(2):201\u2013208","journal-title":"Croat Med J"},{"issue":"2","key":"348_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.pbb.2009.08.012pain","volume":"94","author":"L Bach-Rojecky","year":"2009","unstructured":"Bach-Rojecky L, Lackovi\u0107 Z (2009) Central origin of the antinociceptive action of botulinum toxin type A. Pharmacol Biochem Behav 94(2):234\u2013238. https:\/\/doi.org\/10.1016\/j.pbb.2009.08.012pain","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"348_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00702-004-0265-1","volume":"112","author":"L Bach-Rojecky","year":"2005","unstructured":"Bach-Rojecky L, Relja M, Lackovi\u0107 Z (2005) Botulinum toxin type A in experimental neuropathic pain. J Neural Transm (Vienna) 112(2):215\u2013219. https:\/\/doi.org\/10.1007\/s00702-004-0265-1","journal-title":"J Neural Transm (Vienna)"},{"issue":"1\u20133","key":"348_CR7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2010.01.020","volume":"633","author":"L Bach-Rojecky","year":"2010","unstructured":"Bach-Rojecky L, Salkovi\u0107-Petrisi\u0107 M, Lackovi\u0107 Z (2010) Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection. Eur J Pharmacol 633(1\u20133):10\u201314. https:\/\/doi.org\/10.1016\/j.ejphar.2010.01.020","journal-title":"Eur J Pharmacol"},{"key":"348_CR8","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","volume":"16","author":"E Bomba-Warczak","year":"2016","unstructured":"Bomba-Warczak E, Vevea JD, Brittain JM, Figueroa-Bernier A, Tepp WH, Johnson EA, Yeh FL, Chapman ER (2016) Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons. Cell Rep 16:1974\u20131987. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.104","journal-title":"Cell Rep"},{"issue":"3","key":"348_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/WCO.0000000000000437","volume":"30","author":"R Burstein","year":"2017","unstructured":"Burstein R, Blake P, Schain A, Perry C (2017) Extracranial origin of headache. Curr Opin Neurol 30(3):263\u2013271. https:\/\/doi.org\/10.1097\/WCO.0000000000000437","journal-title":"Curr Opin Neurol"},{"issue":"48","key":"348_CR10","doi-asserted-by":"publisher","first-page":"10329","DOI":"10.1523\/JNEUROSCI.0294-18.2018","volume":"38","author":"M Caleo","year":"2018","unstructured":"Caleo M, Spinelli M, Colosimo F, Matak I, Rossetto O, Lackovic Z, Restani L (2018) Transynaptic action of botulinum neurotoxin type A at central cholinergic boutons. J Neurosci 38(48):10329\u201310337. https:\/\/doi.org\/10.1523\/JNEUROSCI.0294-18.2018","journal-title":"J Neurosci"},{"issue":"6","key":"348_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.eururo.2012.01.046","volume":"61","author":"A Coelho","year":"2012","unstructured":"Coelho A, Cruz F, Cruz CD, Avelino A (2012) Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action. Eur Urol 61(6):1178\u20131184. https:\/\/doi.org\/10.1016\/j.eururo.2012.01.046","journal-title":"Eur Urol"},{"issue":"1","key":"348_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/nau.22445","volume":"33","author":"F Cruz","year":"2014","unstructured":"Cruz F (2014) Targets for botulinum toxin in the lower urinary tract. Neurourol Urodyn 33(1):31\u201338. https:\/\/doi.org\/10.1002\/nau.22445","journal-title":"Neurourol Urodyn"},{"issue":"1\u20132","key":"348_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M, Khanijou S, Rubino J, Aoki KR (2004) Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain 107(1\u20132):125\u2013133. https:\/\/doi.org\/10.1016\/j.pain.2003.10.008","journal-title":"Pain"},{"issue":"7","key":"348_CR14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1177\/0333102410364677","volume":"30","author":"H Diener","year":"2000","unstructured":"Diener H, Dodick DW, Aurora S, Turkel C, DeGryse R, Lipton R, Silberstein S, Brin M (2000) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30(7):804\u2013814. https:\/\/doi.org\/10.1177\/0333102410364677","journal-title":"Cephalalgia"},{"issue":"6","key":"348_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1526-4610.2010.01678.x","volume":"50","author":"DW Dodick","year":"2010","unstructured":"Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener H-C, Brin MF (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache 50(6):921\u2013936. https:\/\/doi.org\/10.1111\/j.1526-4610.2010.01678.x","journal-title":"Headache"},{"issue":"3","key":"348_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/ejp.1146","volume":"22","author":"V Drinovac Vlah","year":"2018","unstructured":"Drinovac Vlah V, Filipovi\u0107 B, Bach-Rojecky L, Lackovi\u0107 Z (2018) Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region. Eur J Pain 22(3):583\u2013591. https:\/\/doi.org\/10.1002\/ejp.1146","journal-title":"Eur J Pain"},{"issue":"1\u20133","key":"348_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejphar.2009.06.047","volume":"617","author":"C Favre-Guilmard","year":"2009","unstructured":"Favre-Guilmard C, Auguet M, Chabrier PE (2009) Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models. Eur J Pharmacol 617(1\u20133):48\u201353. https:\/\/doi.org\/10.1016\/j.ejphar.2009.06.047","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"348_CR18","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/ejp.995","volume":"21","author":"C Favre-Guilmard","year":"2017","unstructured":"Favre-Guilmard C, Chabrier PE, Kalinichev M (2017) Bilateral analgesic effects of abobotulinumtoxinA (Dysport\u00ae) following unilateral administration in the rat. Eur J Pain 21(5):927\u2013937. https:\/\/doi.org\/10.1002\/ejp.995","journal-title":"Eur J Pain"},{"issue":"1","key":"348_CR19","doi-asserted-by":"publisher","first-page":"e29803","DOI":"10.1371\/journal.pone.0029803.e29803","volume":"7","author":"B Filipovi\u0107","year":"2012","unstructured":"Filipovi\u0107 B, Matak I, Bach-Rojecky L, Lackovi\u0107 Z (2012) Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. PLoS One 7(1):e29803. https:\/\/doi.org\/10.1371\/journal.pone.0029803.e29803","journal-title":"PLoS One"},{"issue":"5","key":"348_CR20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00702-013-1144-4","volume":"121","author":"B Filipovi\u0107","year":"2014","unstructured":"Filipovi\u0107 B, Matak I, Lackovi\u0107 Z (2014) Dural neurogenic inflammation induced by neuropathic pain is specific to cranial region. J Neural Transm (Vienna) 121(5):555\u2013563. https:\/\/doi.org\/10.1007\/s00702-013-1144-4","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"348_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1054\/jpai.2003.435","volume":"4","author":"B Freund","year":"2003","unstructured":"Freund B, Schwartz M (2003) Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. J Pain 4(3):159\u2013165. https:\/\/doi.org\/10.1054\/jpai.2003.435","journal-title":"J Pain"},{"issue":"1","key":"348_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/bf00500611","volume":"281","author":"E Habermann","year":"1974","unstructured":"Habermann E (1974) 125I-labeled neurotoxin from Clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedeberg\u2019s Arch Pharmacol 281(1):47\u201356. https:\/\/doi.org\/10.1007\/bf00500611","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"key":"348_CR23","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neulet.2016.02.020","volume":"617","author":"S Ibragi\u0107","year":"2016","unstructured":"Ibragi\u0107 S, Matak I, Dra\u010di\u0107 A, Smajlovi\u0107 A, Muminovi\u0107 M, Sofi\u0107 E, Lackovi\u0107 Z, Riederer P (2016) Effects of botulinum toxin type A facial injection on monoamines and their metabolites in sensory, limbic and motor brain regions in rats. Neurosci Lett 617:213\u2013217. https:\/\/doi.org\/10.1016\/j.neulet.2016.02.020","journal-title":"Neurosci Lett"},{"issue":"Suppl 1","key":"348_CR24","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","volume":"154","author":"RR Ji","year":"2013","unstructured":"Ji RR, Berta T, Nedergaard M (2013) Glia and pain: is chronic pain a gliopathy? Pain 154(Suppl 1):S10\u2013S28. https:\/\/doi.org\/10.1016\/j.pain.2013.06.022","journal-title":"Pain"},{"issue":"4","key":"348_CR25","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.neuroscience.2009.01.066","volume":"159","author":"Y Kitamura","year":"2009","unstructured":"Kitamura Y, Matsuka Y, Spigelman I, Ishihara Y, Yamamoto Y, Sonoyama W, Kamioka H, Yamashiro T, Kuboki T, Oguma K (2009) Botulinum toxin type a (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction. Neuroscience 159(4):1422\u20131429. https:\/\/doi.org\/10.1016\/j.neuroscience.2009.01.066","journal-title":"Neuroscience"},{"key":"348_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fneur.2014.00098","volume":"5","author":"H Koizumi","year":"2014","unstructured":"Koizumi H, Goto S, Okita S, Morigaki R, Akaike N, Torii Y, Harakawa T, Ginnaga A, Kaji R (2014) Spinal central effects of peripherally applied botulinum neurotoxin A in comparison between its subtypes A1 and A2. Front Neurol 5:98. https:\/\/doi.org\/10.3389\/fneur.2014.00098","journal-title":"Front Neurol"},{"issue":"3","key":"348_CR27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/cne.22049","volume":"515","author":"B Kosaras","year":"2009","unstructured":"Kosaras B, Jakubowski M, Kainz V, Burstein R (2009) Sensory innervation of the calvarial bones of the mouse. J Comp Neurol 515(3):331\u2013348","journal-title":"J Comp Neurol"},{"issue":"2","key":"348_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/bph.13366","volume":"173","author":"Z Lackovi\u0107","year":"2016","unstructured":"Lackovi\u0107 Z, Filipovi\u0107 B, Matak I, Helyes Z (2016) Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol 173(2):279\u2013291. https:\/\/doi.org\/10.1111\/bph.13366","journal-title":"Br J Pharmacol"},{"key":"348_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/BJ20111117","volume":"441","author":"GW Lawrence","year":"2012","unstructured":"Lawrence GW, Ovsepian SV, Wang J, Aoki KR, Dolly J (2012) Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmission. Biochem J 441:443\u2013452. https:\/\/doi.org\/10.1042\/BJ20111117","journal-title":"Biochem J"},{"key":"348_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.neuropharm.2013.02.012","volume":"70","author":"GW Lawrence","year":"2013","unstructured":"Lawrence GW, Ovsepian SV, Wang J, Aoki KR, Dolly J (2013) Therapeutic effectiveness of botulinum neurotoxin A: potent blockade of autonomic transmission by targeted cleavage of only the pertinent SNAP25. Neuropharmacology 70:287\u2013295. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.02.012","journal-title":"Neuropharmacology"},{"issue":"1","key":"348_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.neuroscience.2010.08.067","volume":"171","author":"S Marinelli","year":"2010","unstructured":"Marinelli S, Luvisetto S, Cobianchi S, Makuch W, Obara I, Mezzaroma E, Caruso M, Straface E, Przewlocka B, Pavone F (2010) Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. Neuroscience 171(1):316\u2013328","journal-title":"Neuroscience"},{"issue":"10","key":"348_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0047977","volume":"7","author":"S Marinelli","year":"2012","unstructured":"Marinelli S, Vacca V, Ricordy R, Uggenti C, Tata AM, Luvisetto S, Pavone F (2012) The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes. PLoS One 7(10):e47977. https:\/\/doi.org\/10.1371\/journal.pone.0047977","journal-title":"PLoS One"},{"key":"348_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pneurobio.2014.06.00","volume":"119\u2013120","author":"I Matak","year":"2015","unstructured":"Matak I, Lackovi\u0107 Z (2015) Botulinum toxin A, brain and pain. Prog Neurobiol 119\u2013120:39\u201359. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.06.00","journal-title":"Prog Neurobiol"},{"key":"348_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak I, Bach-Rojecky L, Filipovi\u0107 B, Lackovi\u0107 Z (2011) Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience 186:201\u2013207. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.04.026","journal-title":"Neuroscience"},{"issue":"2","key":"348_CR36","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.neuint.2012.05.001","volume":"61","author":"I Matak","year":"2012","unstructured":"Matak I, Riederer P, Lackovi\u0107 Z (2012) Botulinum toxin\u2019s axonal transport from periphery to the spinal cord. Neurochem Int 61(2):236\u2013239. https:\/\/doi.org\/10.1016\/j.neuint.2012.05.001","journal-title":"Neurochem Int"},{"issue":"8","key":"348_CR37","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.pain.2014.04.027","volume":"155","author":"I Matak","year":"2014","unstructured":"Matak I, Rossetto O, Lackovi\u0107 Z (2014) Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons. Pain 155(8):1516\u20131526. https:\/\/doi.org\/10.1016\/j.pain.2014.04.027","journal-title":"Pain"},{"key":"348_CR38","doi-asserted-by":"publisher","unstructured":"Matak I, B\u00f6lcskei K, Bach-Rojecky L, Helyes Z (2019) Mechanisms of botulinum toxin type A action on pain. Toxins (Basel) 11(8). pii: E459. https:\/\/doi.org\/10.3390\/toxins11080459","DOI":"10.3390\/toxins11080459"},{"key":"348_CR39","unstructured":"Michailov VV (1956) Bull Exp Biol Med. USSR 41, 45 (cit. by Tyler 1963)"},{"issue":"1","key":"348_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.20399","volume":"483","author":"JL Morris","year":"2005","unstructured":"Morris JL, K\u00f6nig P, Shimizu T, Jobling P, Gibbins IL (2005) Most peptide-containing sensory neurons lack proteins for exocytotic release and vesicular transport of glutamate. J Comp Neurol 483(1):1\u201316. https:\/\/doi.org\/10.1002\/cne.20399","journal-title":"J Comp Neurol"},{"key":"348_CR41","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.147.3661.1036","volume":"147","author":"EH Polley","year":"1965","unstructured":"Polley EH, Vick JA, Ciuchta HP, Fischetti DA, MacChitelli FJ, Montanarelli N (1965) Botulinum toxin, type A: effects on central nervous system. Science 147:1036\u20131037. https:\/\/doi.org\/10.1126\/science.147.3661.1036","journal-title":"Science"},{"issue":"3","key":"348_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s0304-3959(03)00114-3","volume":"104","author":"R Radhakrishnan","year":"2003","unstructured":"Radhakrishnan R, Moore SA, Sluka KA (2003) Unilateral carrageenan injection into muscle or joint induces chronic bilateral hyperalgesia in rats. Pain 104(3):567\u2013577. https:\/\/doi.org\/10.1016\/s0304-3959(03)00114-3","journal-title":"Pain"},{"issue":"18","key":"348_CR510","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1111\/bph.12763","volume":"171","author":"R Ramachandran","year":"2014","unstructured":"Ramachandran R, Yaksh TL (2014) Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol 171(18):4177\u20134192. https:\/\/doi.org\/10.1111\/bph.12763","journal-title":"Br J Pharmacol"},{"key":"348_CR43","doi-asserted-by":"publisher","unstructured":"Rojewska E, Piotrowska A, Popiolek-Barczyk K, Mika J (2018) Botulinum toxin type A \u2013 a modulator of spinal neuron-glia interactions under neuropathic pain conditions. Toxins (Basel) 10(4). pii: E145. https:\/\/doi.org\/10.3390\/toxins10040145","DOI":"10.3390\/toxins10040145"},{"key":"348_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.toxicon.2018.01.017","volume":"147","author":"Y Safarpour","year":"2018","unstructured":"Safarpour Y, Jabbari B (2018) Botulinum toxin treatment of pain syndromes \u2013 an evidence based review. Toxicon 147:120\u2013128. https:\/\/doi.org\/10.1016\/j.toxicon.2018.01.017","journal-title":"Toxicon"},{"issue":"3","key":"348_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.nbd.2012.07.010","volume":"48","author":"T Shimizu","year":"2012","unstructured":"Shimizu T, Shibata M, Toriumi H, Iwashita T, Funakubo M, Sato H, Kuroi T, Ebine T, Koizumi K, Suzuki N (2012) Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A. Neurobiol Dis 48(3):367\u2013378. https:\/\/doi.org\/10.1016\/j.nbd.2012.07.010","journal-title":"Neurobiol Dis"},{"key":"348_CR47","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.jpain.2007.03.001","volume":"8","author":"M Shinoda","year":"2007","unstructured":"Shinoda M, Kawashima K, Ozaki N, Asai H, Nagamine K, Sugiura Y (2007) P2X3 receptor mediates heat hyperalgesia in a rat model of trigeminal neuropathic pain. J Pain 8:588\u2013597","journal-title":"J Pain"},{"issue":"1","key":"348_CR48","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/1097-4598(200101)24:1<37::aid-mus4>3.0.co;2-8","volume":"24","author":"KA Sluka","year":"2001","unstructured":"Sluka KA, Kalra A, Moore SA (2001) Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 24(1):37\u201346. https:\/\/doi.org\/10.1002\/1097-4598(200101)24:1<37::aid-mus4>3.0.co;2-8","journal-title":"Muscle Nerve"},{"key":"348_CR49","doi-asserted-by":"publisher","unstructured":"Stearns TP, Shad MU, Guzman GC (2018) Glabellar botulinum toxin injections in major depressive disorder: a critical review. Prim Care Companion CNS Disord 20(5). pii: 18r02298. https:\/\/doi.org\/10.4088\/PCC.18r02298","DOI":"10.4088\/PCC.18r02298"},{"issue":"5","key":"348_CR50","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s0041-0101(03)00196-x","volume":"42","author":"DD Tang-Liu","year":"2003","unstructured":"Tang-Liu DD, Aoki KR, Dolly JO, de Paiva A, Houchen TL, Chasseaud LF, Webber C (2003) Intramuscular injection of 125I-botulinum neurotoxin-complex versus 125I-botulinum-free neurotoxin: time course of tissue distribution. Toxicon 42(5):461\u2013469. https:\/\/doi.org\/10.1016\/s0041-0101(03)00196-x","journal-title":"Toxicon"},{"key":"348_CR51","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jpain.2009.09.001","volume":"10","author":"I Tracey","year":"2009","unstructured":"Tracey I, Bushnell MC (2009) How neuroimaging studies have challenged us to rethink: is chronic pain a disease? J Pain 10:1113\u20131120. https:\/\/doi.org\/10.1016\/j.jpain.2009.09.001","journal-title":"J Pain"},{"issue":"4","key":"348_CR52","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1017\/s031716710003540x","volume":"12","author":"JK Tsui","year":"1985","unstructured":"Tsui JK, Eisen A, Mak E, Carruthers J, Scott A, Calne DB (1985) A pilot study on the use of botulinum toxin in spasmodic torticollis. Can J Neurol Sci 12(4):314\u2013316. https:\/\/doi.org\/10.1017\/s031716710003540x","journal-title":"Can J Neurol Sci"},{"key":"348_CR53","doi-asserted-by":"publisher","unstructured":"Tyler HR (1963) Botulinus toxin: effect on the central nervous system of man. Science 139:847\u2013848. https:\/\/doi.org\/10.1126\/science.139.3557.847","DOI":"10.1126\/science.139.3557.847"},{"issue":"3","key":"348_CR54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.bbi.2012.01.002","volume":"26","author":"V Vacca","year":"2012","unstructured":"Vacca V, Marinelli S, Eleuteri C, Luvisetto S, Pavone F (2012) Botulinum neurotoxin A enhances the analgesic effects on inflammatory pain and antagonizes tolerance induced by morphine in mice. Brain Behav Immun 26(3):489\u2013499. https:\/\/doi.org\/10.1016\/j.bbi.2012.01.002","journal-title":"Brain Behav Immun"},{"key":"348_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/bf00498587","volume":"292","author":"H Wiegand","year":"1976","unstructured":"Wiegand H, Erdmann G, Wellh\u00f6ner HH (1976) 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedeberg\u2019s Arch Pharmacol 292:161\u2013165. https:\/\/doi.org\/10.1007\/bf00498587","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"}],"updated-by":[{"DOI":"10.1007\/164_2020_415","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T00:00:00Z","timestamp":1607558400000}}],"container-title":["Handbook of Experimental Pharmacology","Botulinum Toxin Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:43:06Z","timestamp":1722386586000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030663056","9783030663063"],"references-count":54,"URL":"https:\/\/doi.org\/10.1007\/164_2019_348","relation":{"correction":[{"id-type":"doi","id":"10.1007\/164_2020_415","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"4 February 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"10 December 2020","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The chapter was inadvertently published without a more specific title according to SEO guidelines. A chapter title needs to be understandable when seen as a stand-alone item, e.g. on PubMed. The chapter title has now been corrected as \u2018Botulinum Toxin and Pain\u2019.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}